-
-
-
-
-
-
-
COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
-
-
-
-
-
-
-
COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs
-
-
-
-
-
-
-
Cushing® Asset Management and Swank Capital Announce a Constituent Change to The Cushing® MLP High Income Index
-
-
-
-
-
-
-
Cushing® Asset Management and Swank Capital Announce a Constituent Change to The Cushing® MLP Market Cap Index
-
-
-
-
-
-
-
Cushing® Asset Management and Swank Capital Announce a Constituent Change to The Cushing® 30 MLP Index
-
-
-
-
-
-
-
Swank Capital and Cushing® Asset Management Announce a Rebalance of The Cushing® MLP Market Cap Index
-
-
-
-
-
-
-
Swank Capital and Cushing® Asset Management Announce a Constituent Change to The Cushing® MLP High Income Index
-
1,191,254 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

